drugset / Trial / NCT00067912

Duloxetine vs. Active Comparator for the Treatment of Depression

NCT00067912

Phase 4 Completed 480 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

How duloxetine compares to a medication currently available for the treatment of depression in the treatment of patients with major depressive disorder. The safety of duloxetine and any side effects that might be associated with it.

Timeline

Start
2003-04
Primary completion
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule
Subject Venlafaxine Small molecule